• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UsToo前列腺癌特殊提取物调查:研究综述及既往调查结果更新

UsToo PC-SPES surveys: review of studies and update of previous survey results.

作者信息

Porterfield H

机构信息

UsToo International Inc., Oak Brook, Illinois 60523, USA.

出版信息

Mol Urol. 2000 Fall;4(3):289-91;discussion 293.

PMID:11062386
Abstract

In 1997, we resolved to survey UsToo members and other men known at that time to be taking PC-SPES, a Chinese herb combination that contains eight herbs: chrysanthemum, dyers woad, licorice, reishi, san-qi ginseng, rabdosia, saw palmetto, and baikal skullcap. The survey showed positive results, with respondents experiencing a decline in serum prostate specific antigen (PSA), most to the undetectable range. Of these patients, 88% maintained a low PSA concentration, whereas 12% had a rise from nadir. These results made it obvious that we should obtain follow-up reports from the respondents. We therefore conducted a second survey, this time finding 93% of the respondents with positive results and only 7% reporting a rise in PSA after the initial lowering with PC-SPES. Even though there are some side effects, a great majority of men are realizing good PSA control while taking the capsules, and some of the respondents are now into their fourth year of PC-SPES use. Currently, several institutions are investigating the biology of this Chinese herb combination. Although there is some estrogenic effect, there are other potential mechanisms of action to enable this product to control PSA, not only in newly diagnosed cancer, but also in longer-term use.

摘要

1997年,我们决定对UsToo成员以及当时已知正在服用PC-SPES的其他男性进行调查。PC-SPES是一种包含八种草药的中药组合,这八种草药分别是菊花、大青叶、甘草、灵芝、三七、夏枯草、锯叶棕和黄芩。调查结果呈阳性,受访者的血清前列腺特异性抗原(PSA)水平下降,大多数降至检测不到的范围。在这些患者中,88%的人PSA浓度维持在较低水平,而12%的人PSA从最低点开始上升。这些结果表明,我们应该从受访者那里获取后续报告。因此,我们进行了第二次调查,这次发现93%的受访者结果呈阳性,只有7%的人报告在最初服用PC-SPES使PSA降低后又出现了上升。尽管存在一些副作用,但绝大多数男性在服用胶囊时PSA得到了良好控制,一些受访者使用PC-SPES至今已进入第四个年头。目前,几家机构正在研究这种中药组合的生物学特性。尽管它有一些雌激素样作用,但还有其他潜在的作用机制使该产品能够控制PSA,不仅对新诊断的癌症有效,对长期使用也有效。

相似文献

1
UsToo PC-SPES surveys: review of studies and update of previous survey results.UsToo前列腺癌特殊提取物调查:研究综述及既往调查结果更新
Mol Urol. 2000 Fall;4(3):289-91;discussion 293.
2
Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.草药补充剂PC-SPES的作用机制:阐明PC-SPES中各味草药对雄激素依赖性LNCaP细胞增殖及前列腺特异性基因表达的影响。
Int J Oncol. 2002 Mar;20(3):583-8.
3
Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.基因谱分析和启动子报告基因检测:用于比较植物提取物对人前列腺癌细胞的生物学效应并了解其作用机制的新型工具。
Oncogene. 2003 Feb 27;22(8):1261-72. doi: 10.1038/sj.onc.1206242.
4
PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.PC-SPES:一种用于治疗激素难治性前列腺癌的草药疗法。
Prostate Cancer Prostatic Dis. 2002;5(1):13-5. doi: 10.1038/sj.pcan.4500563.
5
Survey of UsToo Members and Other Prostate Cancer Patients to Evaluate the Efficacy and Safety of PC-SPES.对UsToo成员及其他前列腺癌患者进行调查,以评估PC-SPES的疗效和安全性。
Mol Urol. 1999;3(3):333-336.
6
Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.草药化合物(PC-SPES)在激素难治性前列腺癌中的作用:两例病例报告。
J Altern Complement Med. 2000 Oct;6(5):449-51. doi: 10.1089/acm.2000.6.449.
7
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.前列腺癌患者中,草药补充剂PC-SPES与己烯雌酚用于雄激素非依赖性前列腺癌的前瞻性、多中心、随机II期试验。
J Clin Oncol. 2004 Sep 15;22(18):3705-12. doi: 10.1200/JCO.2004.10.195. Epub 2004 Aug 2.
8
Disseminated intravascular coagulation and PC-SPES: a case report and literature review.弥散性血管内凝血与PC-SPES:一例报告及文献综述
Can J Urol. 2001 Aug;8(4):1326-9.
9
Complementary and alternative therapies in prostate cancer.前列腺癌的补充和替代疗法
Semin Oncol. 2002 Dec;29(6):575-84. doi: 10.1053/sonc.2002.50007.
10
Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer.
Oncol Rep. 2008 Mar;19(3):831-5.

引用本文的文献

1
Complementary and alternative medicine in prostate cancer.前列腺癌中的补充与替代医学
Curr Oncol Rep. 2001 Sep;3(5):448-52. doi: 10.1007/s11912-001-0032-5.